Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
28 mars 2024 04h25 HE
|
Clinuvel Pharmaceuticals Limited
Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing in Dusseldorf, Germany.
Malibu shines a light on CLINUVEL’s pioneering work in photomedicine
04 mars 2024 21h38 HE
|
Clinuvel Pharmaceuticals Limited
CLINUVEL joined an intimate evening at Lady Gaga and Michael Polansky's Malibu home to celebrate the future of photomedicine
CLINUVEL Launches CYACÊLLE, Next Generation Solar Care
28 févr. 2023 18h58 HE
|
Clinuvel Pharmaceuticals Limited
UV, HEV protection for individuals at high risk of photoageing and skin cancer MELBOURNE, Australia, March 01, 2023 (GLOBE NEWSWIRE) -- CLINUVEL (ASX: CUV) (Börse Frankfurt: UR9) (ADR Level...
Global SCENESSE® demand drives increased CLINUVEL revenues, earnings
23 févr. 2023 18h14 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Executive summaryPositive Results in the Half Year to 31 December 2022 19% increase in revenues from clinical demand for SCENESSE®...
CLINUVEL Trial Results Show Drug Reduces DNA Damage
15 janv. 2023 18h23 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair disorder show that a new drug – afamelanotide – may be able to reduce the development of...
Letter to shareholders from CLINUVEL’s CEO
29 avr. 2022 01h20 HE
|
Clinuvel Pharmaceuticals Limited
LONDON, April 29, 2022 (GLOBE NEWSWIRE) -- Dear shareholders, friends, Both from a professional viewpoint and as largest private holder, I have felt the urge to share my uncensored mind on...
CLINUVEL progresses innovative DNA Repair Program
10 sept. 2020 03h18 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced the progression of its drug SCENESSE® (afamelanotide 16mg) to treat the disease xeroderma...
CLINUVEL Opens VALLAURIX R&D Centre In Singapore
31 août 2020 05h35 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia and SINGAPORE, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The CLINUVEL Group today announced the opening of its state-of-the-art centralised Research & Development Centre in...
PRÉNUMBRA® - CLINUVEL's Second Afamelanotide Formulation
13 juil. 2020 03h38 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia and SINGAPORE, July 13, 2020 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS today revealed PRÉNUMBRA®, the Company’s second afamelanotide product in development. PRÉNUMBRA® is a...
SCENESSE® to be Prescribed in China
23 avr. 2020 02h08 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia and HANGZHOU, China, April 23, 2020 (GLOBE NEWSWIRE) -- Australian-based company CLINUVEL is launching SCENESSE® (afamelanotide 16mg) in the People’s Republic of China for the...